Substantially improved earnings and continued high growth
January 1 - September 30, 2011
- Net sales rose by 21 % to SEK 109.0 million (89.8)
- The operating result was SEK10.9 million (4.9)
- Profit before tax was SEK 11.2 million (1.2)
- Earnings per share were SEK 0.31 (0.05)
- Cash and cash equivalents at the end of the period were SEK 43.0 million (30.8)
July 1 - September 30, 2011
- Net sales increased by 14 % to SEK 36.5 million (32.0)
- The operating result was SEK 3.7 million (2.2)
- Profit before tax was SEK 6.4 million (-2.1)
- Earnings per share were SEK 0.21 (-0.09)
- CellaVision receives an important order from a large Canadian laboratory
CellaVision in brief
| (SEK million) | Jul-Sep 2011 | Jul-Sep 2010 | Jan-Sep 2011 | Jan-Sep 2010 | Full year 2010 | |
| Net sales | 36.5 | 32.0 | 109.0 | 89.8 | 131.6 | |
| Gross profit | 22.6 | 17.9 | 69.2 | 58.7 | 87.6 | |
| Operating result | 3.7 | 2.2 | 10.9 | 4.9 | 13.9 | |
| Profit before tax | 6.4 | -2.1 | 11.2 | 1.2 | 10.7 | |
| Cash flow | 0.4 | 5.7 | 7.2 | 8.8 | 13.8 | |
CEO's comments: Milestone reached of 1000 analyzers sold and demand continues strong for our products
"Sales and earnings for the third quarter have exceeded my expectations. The reasons for the strong result are mainly increased sales in North America, a good product mix and positive foreign exchange effects. Our contract manufacturers carried out their planned move to a new production site without major disruption and with retained capacity to meet our customers' requested delivery times. Sales for the third quarter rose by 14 per cent and operating profits improved to SEK 3.7 million.
During the quarter we proudly delivered our thousandth analyzer to Southampton in southern England. The event is an important milestone in CellaVision's ten-year history of sales and strengthens us for our continued efforts towards the goal of being a global standard for digital microscopy in the field of hematology. With customers soon in 50 countries, we are recognized by the market as a supplier of products with a high level of customer benefit - and demand for our digital solutions unquestionably exists even outside our main markets.
Our contract manufacturer's move, as I mentioned, has now been completed, giving us the conditions we need to meet expected growth. There is still work to do to secure supply of key components. This may still have a negative impact on the supply situation, but I am confident in our ability to achieve a stable rate of delivery adapted to even higher sales targets before the end of the year.
Nor do we see any dampening effect on sales from the uncertain economic situation in the world. We are entering the last quarter of 2011 still as a growing company, with a strong demand for our products, improved production and supply potential, and a new product on its way."
Yvonne Mårtensson, CEO, CellaVision AB
